Showing results (801-810 of 1,133) with videos related to

Sort By:
Pageof 114
Pigment Cell & Melanoma Research|August 14, 2024
Comparative Transcriptome Analysis Reveals Differential Cutaneous Gene Expression in the Color Variation of Two Ornamental Discus, Red Melon and Red CoverTian Tsyh Ng, Cher Chien Lau, Min Pau Tan, et al.
Pigment Cell & Melanoma Research|June 6, 2024
Two-pore channel 2 is required for soluble adenylyl cyclase-dependent regulation of melanosomal pH and melanin synthesisDalee Zhou, Zuhal Eraslan, Dawson Miller, et al.
Pigment Cell & Melanoma Research|May 10, 2024
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatmentHsin-Yi Tseng, Sara Alavi, Stuart Gallagher, et al.
Pigment Cell & Melanoma Research|May 11, 2024
An in vitro nevus explant model for studying the effects of ultraviolet radiationRui Wang, Jianglong Feng, Wei Zhang, et al.
Pigment Cell & Melanoma Research|April 16, 2024
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy responseYanhong Wu, Hongying He, Kairong Zheng, et al.
Pigment Cell & Melanoma Research|February 11, 2026
Rare Germline Variants in CDKN2A-Negative Children and Adolescents With Cutaneous MelanomaPeter A Johansson, Jane M Palmer, Linh T Bui-Raborn, et al.
Pigment Cell & Melanoma Research|November 24, 2025
SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF-β Signaling PathwayHongzhou Cui, Jianhua Hao, Qiong Wang, et al.
Pigment Cell & Melanoma Research|January 5, 2024
Molecular skin fluorescence imaging: A tool for evaluating early melanoma developmentAmit Shachaf, Kevin Manbeck, Guang Yang, et al.
Pigment Cell & Melanoma Research|December 29, 2023
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysisViktoria Rydén, Ali Inan El-Naggar, Anthoula Koliadi, et al.
Pigment Cell & Melanoma Research|December 28, 2023
Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patientsEsperanza Manrique-Silva, Millán-Esteban David, Aguerralde-Martin Maider, et al.
Pageof 114